Life Science

Department of Microbiology & Immunology University of Illinois Chicago - Through cloning and sequence analysis, researchers have identified the primary gene of the hereditary disease muscular dystrophy, thus leading to the characterizing of the primary protein product. Deletions contributing to an absence of the polypeptide dystrophin (0.002% of total muscle protein and 3,685 amino acids long) on the inner surface of the plasma membrane appear to be the primary cause for two types of muscul

Written bySimon Silver
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Department of Microbiology & Immunology
University of Illinois
Chicago

- Through cloning and sequence analysis, researchers have identified the primary gene of the hereditary disease muscular dystrophy, thus leading to the characterizing of the primary protein product. Deletions contributing to an absence of the polypeptide dystrophin (0.002% of total muscle protein and 3,685 amino acids long) on the inner surface of the plasma membrane appear to be the primary cause for two types of muscular dystrophy. The polypeptide may play cytoskeletal roles, since it is sequence-related to spectrin and à-actinin.

A.P. Monaco, "Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene," Trends in Biochemical Sciences, 14, 412-5, October 1989. (Imperial Cancer Research Fund, London)

O. Olsson, A. Escher, G. Sandberg, J. Schell, et al., "Engineering of monomeric bacterial luciferases by fusion of luxA and luxB genes in Vibrio harveyi," Gene, 81 (2), 335-47, October 1989. (University of Ume , ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies